Upstream Bio, Inc.
UPB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $2,370 | $2,380 | $1,212 |
| % Growth | -0.4% | 96.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $2,370 | $2,380 | $1,212 |
| % Margin | 100% | 100% | 100% |
| R&D Expenses | $62,966 | $31,799 | $18,657 |
| G&A Expenses | $17,168 | $10,695 | $6,464 |
| SG&A Expenses | $17,168 | $10,695 | $6,464 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $80,134 | $42,494 | $25,121 |
| Operating Income | -$77,764 | -$40,114 | -$23,909 |
| % Margin | -3,281.2% | -1,685.5% | -1,972.7% |
| Other Income/Exp. Net | $14,958 | $19,577 | $41 |
| Pre-Tax Income | -$62,806 | -$20,537 | -$23,868 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$62,806 | -$20,537 | -$23,868 |
| % Margin | -2,650% | -862.9% | -1,969.3% |
| EPS | -1.49 | -1.05 | -0.66 |
| % Growth | -41.9% | -59.1% | – |
| EPS Diluted | -1.49 | -1.05 | -0.66 |
| Weighted Avg Shares Out | 51,342 | 36,323 | 36,323 |
| Weighted Avg Shares Out Dil | 51,342 | 36,323 | 36,323 |
| Supplemental Information | – | – | – |
| Interest Income | $12,123 | $4,165 | $205 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $89 | $60 | $7 |
| EBITDA | -$77,675 | -$40,054 | -$23,902 |
| % Margin | -3,277.4% | -1,682.9% | -1,972.1% |